TipRanks
Go Ultimate55% OFF

Sinopharm Group Co (X2S1) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

X2S1 Analyst Ratings

There are no analyst ratings in the last 3 months.

X2S1 Stock 12 Month Forecast

There are no analyst price targets in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:X2S1
Price TargetFollowArticle
TipRanks - PerPlexityEUR 9.82buy9.10%UpsideUpgraded10/26/26
TipRanks - GoogleEUR 9.82buy9.10%UpsideUpgraded10/26/26
TipRanks - AnthropicEUR 8.93hold-0.81%DownsideReiterated10/26/26
TipRanks - OpenAIEUR 9.37hold4.14%UpsideReiterated10/26/26
TipRanks - DeepSeekEUR 8.93hold-0.81%DownsideReiterated10/26/26
TipRanks - xAIEUR 9.37hold4.14%UpsideReiterated10/26/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sinopharm Group Co

3 Months
Success Rate0/2 ratings generated profit
0%
Average Return
-0.65%

Copying Google Medical - Distribution's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -0.65% per trade.

1 Year
Success Rate0/2 ratings generated profit
0%
Average Return
-0.65%

Copying Google Medical - Distribution's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -0.65% per trade.

2 Years
Success Rate0/2 ratings generated profit
0%
Average Return
-0.65%

Copying Google Medical - Distribution's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -0.65% per trade.

X2S1 Analyst Recommendation Trends

00.511.52Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for X2S1
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy00000
Buy00000
Hold00000
Sell00000
Strong Sell00000
total00000

In the current month, X2S1 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. X2S1 average Analyst price target in the past 3 months is ―.

X2S1 Financial Forecast

EUR -1EUR 9.2BEUR 18.4BEUR 27.6BEUR 36.8BQ2 2025Q2 2026Q4 2026
ConsensusEUR 0.00

X2S1 Sales Forecast

Next quarter’s sales forecast for X2S1 is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 36.77B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

X2S1 Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Sinopharm Group Co?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Sinopharm Group Co?
To buy shares of DE:X2S1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.